Moneycontrol PRO
ipca laboratories
Jump to
391 Results Found
  • These 5 companies surprised investors with Q1 show; experts see an upside of 14-33% Aug 22, 2020 01:36 PM IST

    These 5 companies surprised investors with Q1 show; experts see an upside of 14-33%

    With robust performance amid challenging times, Airtel is one of the better placed telecom players, ICICI Direct said.

  • Buy Ipca Laboratories; target of Rs 2420: Motilal Oswal Aug 13, 2020 03:02 PM IST

    Buy Ipca Laboratories; target of Rs 2420: Motilal Oswal

    Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2420 in its research report dated August 11, 2020.

  • Hold Ipca Laboratories; target of Rs 1962: Prabhudas Lilladher Aug 13, 2020 03:02 PM IST

    Hold Ipca Laboratories; target of Rs 1962: Prabhudas Lilladher

    Prabhudas Lilladher recommended Hold rating on Ipca Laboratories with a target price of Rs 1962 in its research report dated August 12, 2020.

  • Buy Ipca Laboratories; target of Rs 2365: Sharekhan Aug 12, 2020 05:38 PM IST

    Buy Ipca Laboratories; target of Rs 2365: Sharekhan

    Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2365 in its research report dated August 11, 2020.

  • Buy Ipca Laboratories; target of Rs 2400: ICICI Direct Aug 12, 2020 03:29 PM IST

    Buy Ipca Laboratories; target of Rs 2400: ICICI Direct

    ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 11, 2020.

  • Accumulate IPCA Laboratories ; target of Rs 2106: Dolat Capital Aug 12, 2020 03:26 PM IST

    Accumulate IPCA Laboratories ; target of Rs 2106: Dolat Capital

    Dolat Capital recommended accumulate rating on IPCA Laboratories with a target price of Rs 2106 in its research report dated August 12, 2020.

  • Ipca Labs Standalone June 2020 Net Sales at Rs 1,485.25 crore, up 46.91% Y-o-Y Aug 10, 2020 04:33 PM IST

    Ipca Labs Standalone June 2020 Net Sales at Rs 1,485.25 crore, up 46.91% Y-o-Y

  • Ipca Labs Consolidated June 2020 Net Sales at Rs 1,534.40 crore, up 42.31% Y-o-Y Aug 10, 2020 04:33 PM IST

    Ipca Labs Consolidated June 2020 Net Sales at Rs 1,534.40 crore, up 42.31% Y-o-Y

  • USFDA has removed partial lifting of import alert on APIs manufacturing facility at Ratlam: Ipca Laboratories Jun 24, 2020 12:04 PM IST

    USFDA has removed partial lifting of import alert on APIs manufacturing facility at Ratlam: Ipca Laboratories

    In a regulatory filing Ipca Laboratories said, the US Food and Drug Administration (USFDA) has informed the company that the "shortage implications for chloroquine phosphate API has changed and chloroquine phosphate drug product is no longer in shortage and therefore, no shipment of API chloroquine phosphate will be excluded from the import alert."

  • Buy Ipca Laboratories; target of Rs 1750: Sharekhan Jun 18, 2020 06:26 PM IST

    Buy Ipca Laboratories; target of Rs 1750: Sharekhan

    Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1750 in its research report dated June 17, 2020.

  • Buy Ipca Laboratories; target of Rs 1839: Prabhudas Lilladher Jun 18, 2020 06:20 PM IST

    Buy Ipca Laboratories; target of Rs 1839: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1839 in its research report dated June 17, 2020.

  • Accumulate IPCA Laboratories; target of Rs 1600: Dolat Capital Jun 18, 2020 06:14 PM IST

    Accumulate IPCA Laboratories; target of Rs 1600: Dolat Capital

    Dolat Capital recommended accumulate rating on IPCA Laboratories with a target price of Rs 1600 in its research report dated June 17, 2020.

  • Buy Ipca Laboratories; target of Rs 1900: ICICI Direct Jun 18, 2020 06:06 PM IST

    Buy Ipca Laboratories; target of Rs 1900: ICICI Direct

    ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated June 17, 2020.

  • Buy IPCA Laboratories; target of Rs 1782: Emkay Global Financial Jun 18, 2020 05:54 PM IST

    Buy IPCA Laboratories; target of Rs 1782: Emkay Global Financial

    Emkay Global Financial is bullish on IPCA Laboratories has recommended buy rating on the stock with a target price of Rs 1782 in its research report dated June 17, 2020.

  • Ipca Labs Standalone March 2020 Net Sales at Rs 1,004.79 crore, up 20.51% Y-o-Y Jun 17, 2020 09:22 AM IST

    Ipca Labs Standalone March 2020 Net Sales at Rs 1,004.79 crore, up 20.51% Y-o-Y

  • Ipca Labs Consolidated March 2020 Net Sales at Rs 1,073.76 crore, up 22.07% Y-o-Y Jun 17, 2020 09:16 AM IST

    Ipca Labs Consolidated March 2020 Net Sales at Rs 1,073.76 crore, up 22.07% Y-o-Y

  • Explained | Why is Hydroxychloroquine under global spotlight? Apr 15, 2020 02:30 PM IST

    Explained | Why is Hydroxychloroquine under global spotlight?

    Moneycontrol's Shraddha Sharma explains what Hydroxychloroquine or HCQ is and why its demand is on a rise

  • Coronavirus pandemic opens up a huge opportunity for Indian pharma Apr 14, 2020 08:53 AM IST

    Coronavirus pandemic opens up a huge opportunity for Indian pharma

    Local drug companies should address some of the longer term issues concerning the industry such as quality and good manufacturing practices

  • Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19 Mar 31, 2020 01:16 PM IST

    Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19

    Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.

  • Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine Mar 23, 2020 09:56 AM IST

    Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine

    The stock gained over 62 percent in the last 6 months and was trading with volumes of 19,120 shares

  • Slideshow | Cipla, IRB Infra among 5 stocks that can give 17-39% return Feb 28, 2020 11:47 AM IST

    Slideshow | Cipla, IRB Infra among 5 stocks that can give 17-39% return

    Here are the top five stocks, which are likely to give return of 17-39 percent:

  • Buy Ipca Laboratories; target of Rs 1826: Prabhudas Lilladher Feb 20, 2020 12:08 PM IST

    Buy Ipca Laboratories; target of Rs 1826: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1826 in its research report dated February 13, 2020.

  • Buy Ipca Laboratories target of Rs 1590: Sharekhan Feb 14, 2020 03:36 PM IST

    Buy Ipca Laboratories target of Rs 1590: Sharekhan

    Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1590 in its research report dated February 13, 2020.

  • Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y Feb 14, 2020 03:00 PM IST

    Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y

  • Ipca Labs at record close, up 6% on strong Q3 revenue growth Feb 12, 2020 04:23 PM IST

    Ipca Labs at record close, up 6% on strong Q3 revenue growth

    Domestic formulations segment registered a 15% growth YoY at Rs 485.6 crore and exports grew 25% to Rs 585.6 crore in Q3FY20.

Sections
ISO 27001 - BSI Assurance Mark